We provide neurodegenerative disease patients with expert MDs and 24/7 wrap around care, no matter where you live in the US
Synapticure has raised $25.0M in total funding. The most recent round was Series A. The last funding was announced in November 2024.
Synapticure's investors include Y Combinator, B Capital, RA Capital Management, Rebel Fund, Optum Ventures.
Synapticure is headquartered in Chicago, United States.
We provide neurodegenerative disease patients with expert MDs and 24/7 wrap around care, no matter where you live in the US
Synapticure is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Synapticure — Funding & Investors." VCBacked, November 19, 2024, https://www.vcbacked.co/company/synapticure. Accessed July 19, 2026.
VCBacked. (2024). Synapticure — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/synapticure
{{cite web |title=Synapticure — Funding & Investors |url=https://www.vcbacked.co/company/synapticure |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated